Molecular and Cellular Biochemistry

, Volume 288, Issue 1–2, pp 107–113 | Cite as

Garlic Compound, Diallyl Disulfide Induces Cell Cycle Arrest in Prostate Cancer Cell Line PC-3

  • Arumugam Arunkumar
  • Marati Radhakrishnan Vijayababu
  • Narasimman Srinivasan
  • Maria Michael Aruldhas
  • Jagedeesan ArunakaranEmail author


Prostate cancer is the most predominant cancer in men and related death rate increases every year. Till date, there is no effective therapy for androgen independent prostate cancer. Previous studies reported that aged garlic extract suppresses cancer growth. In the present study, diallyl disulfide [DADS], oil soluble organosulfur compound of garlic, was studied for its antiproliferative and induction of cell cycle arrest on prostate cancer cells in vitro. The suppression of cell growth was assessed by MTT assay. Induction of cell cycle arrest was assessed and confirmed by propidium iodide staining in flowcytometric analysis and western blotting analysis of major cell cycle regulator proteins. The results showed that DADS inhibited the growth of prostate cancer cells in a dose dependent manner, compared to the control. At 25 μM and 40 μM concentrations, DADS induced cell cycle arrest at G2/M transition in PC-3 cells. Western blotting analysis of cyclin A, B1 and cyclin dependent kinase 1 [CDK1] revealed that DADS inhibited the cell cycle by downregulating CDK1 expression. It is concluded that DADS, inhibits proliferation of prostate cancer cells through cell cycle arrest. Dose dependent effect of DADS on PC-3 cell line was observed in the present study.


cell cycle arrest cyclins cyclin dependent kinase diallyl disulfide prostate cancer 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jemal A, Thomas A, Murray T, Thun M: Cancer statistics, 2002. CA Cancer J Clin 52: 23–47, 2002PubMedCrossRefGoogle Scholar
  2. 2.
    Kish JA, Bukkapatnam R, Palazzo F: The treatment challenge of hormone-refractory prostate cancer. Cancer Control 8: 487–495, 2001PubMedGoogle Scholar
  3. 3.
    Brawley OW, Barnes S, Parnes H: The future of prostate cancer prevention. Ann NY Acad Sci 952: 145–152, 2001PubMedCrossRefADSGoogle Scholar
  4. 4.
    Breslow N, Chan C, Dhom G, Drury R, Franks L, Gellei B, Lee Y, Lundberg S, Sparke B, Sternby N, Tulinius H: Latent carcinoma of the prostate at autopsy in seven areas. Int J Cancer 20: 680–688, 1977PubMedGoogle Scholar
  5. 5.
    Flanders W: Prostate cancer epidemiology. Prostate 5: 621–629, 1984PubMedGoogle Scholar
  6. 6.
    Haenszel W, Kurihara M: Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40: 43–68, 1968PubMedGoogle Scholar
  7. 7.
    Severson R, Nomura A, Grove J, Stemmermann G: A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49: 1857–1860, 1989PubMedGoogle Scholar
  8. 8.
    Adlercreutz H: Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 50 (Suppl.): 3–23, 1990Google Scholar
  9. 9.
    Hsing AW, Chokkalingam AP, Gao YT, Madigan MP, Deng J, Gridley G, Fraumeni Jr JF: Allium vegetables and risk of prostate cancer: a population-based study, J Natl Cancer Inst 94: 1648–1651, 2002PubMedGoogle Scholar
  10. 10.
    Milner JA: Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis. Adv Exp Med Biol 492: 69–81, 2001PubMedGoogle Scholar
  11. 11.
    Siegel G, Malmsten M, Pietzsch J, Schmidt A, Buddecke E, Michel F, Ploch M, Schneider W: The effect of garlic on arteriosclerotic nanoplaque formation and size. Int J Phytotherapy Phytopharmacol 11: 24–35, 2004Google Scholar
  12. 12.
    Tsao S, Yin M: In vitro activity of garlic oil and four diallyl sulphides against antibiotic-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae. J Antimicrobial Chemotherapy 47: 665–670, 2001CrossRefGoogle Scholar
  13. 13.
    Kwon MJ, Song YS, Choi MS, Park SJ, Jeong KS, Song YO: Cholesteryl ester transfer protein activity and atherogenic parameters in rabbits supplemented with cholesterol and garlic powder. Life Sci 72: 2953–2964, 2003PubMedCrossRefGoogle Scholar
  14. 14.
    Hong YS, Ham YA, Choi JH, Kim J: Effects of allyl sulfur compounds and garlic extract on the expression of Bcl-2. Bax, and p53 in non small cell lung cancer cell lines. Exp Mol Med 32: 127–134, 2000PubMedGoogle Scholar
  15. 15.
    Nakagawa H, Tsuta K, Kiuchi K, Senzaki H, Tanaka K, Hioki A, Tsubura A: Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis 22: 891–897, 2001PubMedCrossRefGoogle Scholar
  16. 16.
    Takezaki T, Gao CM, Wu JZ, Ding JH, Liu YT, Zhang Y, Li SP, Su P, Liu TK, Tajima K: Dietary protective and risk factors for esophageal and stomach cancers in a low-epidemic area for stomach cancer in Jiangsu Province. China: comparison with those in a high-epidemic area. Jap J Cancer Res 92: 1157–1165, 2001Google Scholar
  17. 17.
    Iimuro M, Shibata H, Kawamori T, Matsumoto T, Arakawa T, Sugimura T, Wakabayashi K: Suppressive effects of garlic extract on Helicobacter pylori-induced gastritis in Mongolian gerbils. Cancer Lett 187: 61–68, 2002PubMedCrossRefGoogle Scholar
  18. 18.
    Ku DD, Abdel-Razek TT, Dai J, Kim-Park S, Fallon MB, Abrams GA: Garlic and its active metabolite allicin produce endothelium- and nitric oxide-dependent relaxation in rat pulmonary arteries. Clin Exp Pharmacol Physiol 29: 84–91, 2002PubMedCrossRefGoogle Scholar
  19. 19.
    Guyonnet D, Belloir C, Suschetet M, Siess MH, Le Bon AM: Liver subcellular fractions from rats treated by organosulfur compounds from Allium modulate mutagen activation. Mutat Res 466: 17–26, 2000PubMedGoogle Scholar
  20. 20.
    Le Bon AM, Roy C, Dupont C, Suschetet M: In vivo antigenotoxic effects of dietary allyl sulfides in the rat. Cancer Lett 114: 131–134, 1997PubMedCrossRefGoogle Scholar
  21. 21.
    Sheen LY, Wu CC, Lii CK, Tsai SJ: Effect of diallyl sulfide and diallyl disulfide, the active principles of garlic, on the aflatoxin B-1-induced DNA damage in primary rat hepatocytes. Toxicol. Lett 122: 45–52, 2001PubMedCrossRefADSGoogle Scholar
  22. 22.
    Guyonnet D, Belloir C, Suschetet M, Siess MH, Le Bon AM: Antimutagenic activity of organosulfur compounds from Allium is associated with phase II enzyme induction. Mutat Res 495: 135–145, 2001PubMedGoogle Scholar
  23. 23.
    Siess MH, Le Bon AM, Canivenc-Lavier MC, Suschetet M: Modification of hepatic drug-metabolizing enzymes in rats treated with alkyl sulfides. Cancer Lett 120: 195–201, 1997PubMedCrossRefGoogle Scholar
  24. 24.
    Hu X, Singh SV: Glutathione S-transferases of female A/J mouse lung and their induction by anticarcinogenic organosulfides from garlic. Arch Biochem Biophys 340: 279–286, 1997PubMedCrossRefGoogle Scholar
  25. 25.
    Guyonnet D, Siess MH, Le Bon AM, Suschetet M: Modulation of phase II enzymes by organosulfur compounds from allium vegetables in rat tissues. Toxicol Appl Pharmacol 154: 50–58, 1999PubMedCrossRefGoogle Scholar
  26. 26.
    Knowles LM, Milner JA: Allyl sulfides modify cell growth. Drug Metabol Drug Interact 17: 81–107, 2000PubMedGoogle Scholar
  27. 27.
    Sundaram SG, Milner JA: Diallyl disulfide suppresses the growth of human colon tumor cell xenografts in athymic nude mice. J Nutr 126: 1355–1361, 1996PubMedGoogle Scholar
  28. 28.
    Arunkumar A, Vijayababu MR, Kanagaraj P, Balasubramanian K, Aruldhas MM, Arunakaran J: Growth suppressing effect of garlic compound diallyl disulfide on prostate cancer cell line (PC-3) in vitro. Biol Pharm Bull 28: 740–743, 2005PubMedCrossRefGoogle Scholar
  29. 29.
    Gunadharini DN, Arunkumar A, Krishnamoorthy G, Muthuvel R, Vijayababu MR, Kanagaraj P, Srinivasan N, Aruldhas MM, Arunakaran J: Antiproliferative effect of diallyl disulfide (DADS)on prostatic cancer cell line (LNCaP). Cell Biochem Func 23: 1–6, 2005CrossRefGoogle Scholar
  30. 30.
    Yuan JP, Ling H, Zhang MX, Liu Y, Song Y, Su Q: Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways, Ai Zheng 23: 169–172, 2004PubMedGoogle Scholar
  31. 31.
    Rasola A, Geuna M: A flowcytometry assay simultaneously detects independent apoptotic parameters. Cytometry 45: 151–157, 2001PubMedCrossRefGoogle Scholar
  32. 32.
    Lawson LD, Wang ZJ: Pre-hepatic fate of the organosulfur compounds derived from garlic [Allium sativum]. Planta Med 59: A688–689, 1993Google Scholar
  33. 33.
    Dausch JG, Nixon DW: Garlic: A review of its relationship to malignant disease. Prev Med 19: 346–61, 1990PubMedCrossRefGoogle Scholar
  34. 34.
    Druesne N, Pagniez A, Mayeur C, Thomas M, Cherbuy C, Duee PH, Martel P, Chaumontet C: Diallyl disulfide (DADS)increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines. Carcinogenesis 25: 1227–1236, 2004PubMedCrossRefGoogle Scholar
  35. 35.
    Yuan JP, Ling H, Zhang MX, Liu Y, Song Y, Su Q: Diallyl disulfide induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways, Ai Zheng 23: 169–172, 2004PubMedGoogle Scholar
  36. 36.
    Knowles LM, Milner JA: Depressed p34cdc2 kinase activity and G2/M phase arrest induced by diallyl disulfide in HCT-15 cells, Nutr Cancer 30: 169–174, 1998PubMedCrossRefGoogle Scholar
  37. 37.
    Wu CC, Chung JG, Tsai SJ, Yang JH, Sheen LY: Differential effects of allyl sulfides from garlic essential oil on cell cycle regulation in human liver tumor cells. Food Chemical Toxicol 42: 1937–1947, 2004CrossRefGoogle Scholar
  38. 38.
    King RW, Jackson PK, Kirschner MW: Mitosis in transition. Cell 79: 563–571, 1994PubMedCrossRefGoogle Scholar
  39. 39.
    Coleman TR, Dunphy WG: Cdc2 regulatory factors. Curr Opin Cell Biol 6: 877–882, 1994PubMedCrossRefGoogle Scholar
  40. 40.
    Obaya AJ, Sedivy JM: Regulation of cyclin-Cdk activity in mammalian cells. Cell Mol Life Sci 59: 126–142, 2002PubMedCrossRefGoogle Scholar
  41. 41.
    Bulavin DV, Higashimoto Y, Popoff I, Gaarde W, Basrur V, Potapova O, Appella E, Fornace A: Initiation of a G2/M checkpoint after ultraviolet radiation require p38 kinase. Nature 411: 102–106, 2001PubMedCrossRefADSGoogle Scholar
  42. 42.
    Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica- Worms H. Mitotic and G2 checkpoint control: Regulation of 14-3-3-protein binding by phosphorylation of cdc25C on serine- 216. Science 277: 1501–1505, 1997PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Arumugam Arunkumar
    • 1
  • Marati Radhakrishnan Vijayababu
    • 1
  • Narasimman Srinivasan
    • 1
  • Maria Michael Aruldhas
    • 1
  • Jagedeesan Arunakaran
    • 1
    Email author
  1. 1.Department of Endocrinology, Dr. ALM PG Institute of Basic Medical SciencesUniversity of MadrasChennaiIndia

Personalised recommendations